InvestorsHub Logo

loanranger

06/09/23 5:58 PM

#398186 RE: williamssc #398185

"Bril disrupts the cell wall and this action coupled with fungistatic CAS make a fungicide."
So what's next?

It sounds like a clinical trial is the obvious next step. When I suggested earlier that that might be the case I was asked:
"What would motivate them (Merck) to combine it with Brilacidin to Kill the fungi and thus end the need for further treatment once the fungi has been eradicated?"

So if IPIX can't afford a trial and it's not in Merck's interest, what's next? How does this Company cash in on your "Bril disrupts the cell wall and this action coupled with fungistatic CAS make a fungicide" magic?
Or is this just another Dead End?

Lemoncat

06/10/23 1:13 PM

#398197 RE: williamssc #398185

It's so good, right? Let's sign a deal with a partner to develop it then.